Development of a serum-free producer cell line generation process for scalable and efficient rAAV production for gene therapy applications

Key Points

• Efficient production process leads to enhanced rAAV yield for gene therapy applications, ensuring scalability.
• The development of a novel serum-free method showcases significant improvements in overall production efficiency and stability.
• Analysis used a systematic approach to generate stable producer cell lines suitable for large-scale rAAV production.
• This work highlights the potential of serum-free methods in reducing production costs while enhancing product quality for gene therapies.